Bayer adds Mullen Lowe to its global ad agency portfolio

expanded its advertising agency roster by adding Mullen Lowe to its consumer health arm, Interpublic Group. The agency won new business after a review by Bayer's competition agency, which aims to consolidate and modernize its global marketing.A Bayer Consumer Health spokesman said Mullen Lowe would focus on brands based on its Basel strategic business unit, including vitamin supplement Booka, antifelectocial cream carnitine and heartburn drug Rennie. This brand portfolio was previously the responsibility of JWT.The mission will begin in January 2020 and Mullen Lowe will be carried out at its UK office.The
to simplify and accelerate drug development with the MarkLogic data center services of research and development pharmaceutical companies
researchers often don't get the information they need. And even if the data is indeed consolidated, researchers find it difficult to filter and understand all the data so that they can confidently draw the right conclusions and share the right results. Learn how to quickly and easily find, synthesize, and share information to accelerate and improve research and development.
Read more
other agencies, including OMnicom Group's BBDO, which deals with brands such as Aspirin and Clarion, will also remain committed to Bayer's consumer brands.Related: Bayer sells Dr. Schul's foot care brandBayer to buy Merck's consumer business in 2014 as major reforms move forward, but the division has been the subject of much selling since then. After talking about sales across the division, Bayer last year sold two separate brands from Merck, Copoton Sunscreen and Dr. Shure's Foot Care, for a total of $1.14 billion.Bayer's consumer health division reported third-quarter sales of 1.29 billion yuan ($1.23 billion), up 3.7 percent from a year earlier. （cyy123.com）